	Is early combination therapy associated with lower risk of respiratory failure in severely immunocompromised hosts with COVID-19? a target trial emulation study from the omicron-dominant era. Eur J Clin Microbiol Infect Dis Bavaro DF, Diella L, Belati A, Pellegrino C, De Vita G, Bruno G, Poliseno M, Bottalico IF, Ieva FRP, De Gregorio F, Pallara E, Muscatiello C, Di Gennaro F, Bussini L, Bartoletti M, Buccoliero GB, Lo Caputo S, Saracino A, Carbonara S. PMID: 42593592 [PubMed - as supplied by publisher]
	Harnessing the quinoline core for targeted cancer therapy. Future Med Chem Liu CJ, Huang WW, Wang JJ, Jiang WS, Zhang XY, Chen X, Gao Y, Dai XJ. PMID: 42593423 [PubMed - as supplied by publisher]
	From Multi-Omics to Mechanism: Nucleocapsid-RCHY1-JUNB Axis Underlies SARS-CoV-2 Related Atrial Fibrillation Vulnerability. Europace Xiang C, Zhu Y, Zhao W, Zhao P, Hua Y, Xu R, Huang Y, Von Brunn A, Zhang D, Zhang F. PMID: 42592859 [PubMed - as supplied by publisher]
	Patient burden of chemosensory dysfunction and long COVID. Dan Med J Hansen JS, Rohde M, Fjældstad AW. PMID: 42592765 [PubMed - indexed for MEDLINE]
	SARS-CoV-2 Neutralization Breadth Is Shaped by Variant Exposure and Immune History. J Med Virol Vizgirda G, Underwood AP, Fahnøe U, Sølund C, Villadsen SL, Galli A, Weis N, Bukh J. PMID: 42592680 [PubMed - indexed for MEDLINE]
	Nanobodies targeting SARS-CoV-2 variants. Acta Pharm Sin B Roy A, Yang Y, Du L. PMID: 42592525 [PubMed]
	BCG-induced trained immunity on clinical outcomes in moderate to severe COVID-19 patients at a tertiary care center: A comparative study based on interferon-gamma release assays status. J Family Med Prim Care Goel AD, Ramankutty NT, Mantri N, Kumar N, Kundu A, Gadepalli RS, Sharma A, Gupta MK, Bhardwaj P, Saurabh S, Dutt N, Bhatia P, Sharma P, Garg MK, Nag VL, Misra S. PMID: 42592253 [PubMed]
	Glucose metabolism across COVID-19 and long COVID: a longitudinal study. J Endocr Soc Daher J, Koberssy Z, Diaz M, Zisis SN, Rosen CJ, McComsey GA. PMID: 42591780 [PubMed]
	Integrated meta-analysis of human astrocytes transcriptomes reveals a candidate recurrent inflammatory signature in response to inflammatory and immune stimuli. Front Cell Neurosci Luque-Bolivar A, Ruiz-Araujo K, Aristizábal-Pachón AF, González J. PMID: 42591297 [PubMed]
	The challenge of patient recruitment into early phase clinical trials: Is time-effective academic translational research feasible? Lessons from a phase I/II trial in patients with B-cell deficiencies. Front Med (Lausanne) Marconato M, Jäger S, Tegeler CM, Hackenbruch C, Salih HR, Walz JS, Federmann B, Heitmann JS. PMID: 42591123 [PubMed]
	NeuroCOVID Burden and Functional Impairment in Adults with Long COVID: A Secondary Analysis of an Italian Cohort. J Clin Med Cianciulli A, Santoro E, Manente R, Figura M, Pacifico A, Boccia G. PMID: 42590129 [PubMed]
	Haptoglobin Phenotypes Stratify Post-Exertional Cognitive Dysfunction Associated with Altered Cerebral Oxygenation and Metabolic Signatures in Long COVID. Int J Mol Sci Moezzi A, Elremaly W, Leveau C, Franco A, Nepotchatykh O, Armstrong CW, Moreau A. PMID: 42589652 [PubMed - indexed for MEDLINE]
	Involvement of NLRP3 Inflammasome in Methamphetamine Augmentation of SARS-CoV-2 N-Protein-Induced Neuroinflammation in Rat Microglial Cells. Int J Mol Sci Dutta D, Liu J, Xiong H. PMID: 42589614 [PubMed - indexed for MEDLINE]
	Neurodegenerative and Cognitive Consequences of Long COVID. Int J Mol Sci Marek-Józefowicz L, Borkowska A, Nedoszytko B, Cuba, Purzycka-Bohdan D, Bohdan M. PMID: 42589551 [PubMed - indexed for MEDLINE]
	Targeting the NLRP3 Inflammasome with Colchicine in COVID-19: Therapeutic Evidence and Future Implications for Influenza. Int J Mol Sci Mitev V. PMID: 42589484 [PubMed - indexed for MEDLINE]
	SARS-CoV-2 Infection-Induced Alterations in ADAR Editing Patterns Differ Between Patients Who Developed Critical Compared to Non-Critical COVID-19. Int J Mol Sci Mukundan Nair A, Piontkivska H. PMID: 42589470 [PubMed - indexed for MEDLINE]
	Dose-Dependent Influence of RBD-Derived Amyloidogenic Peptides on SARS-CoV-2 Infectivity: A Cautionary Tale for Antiviral Design. Int J Mol Sci Nikiforova MA, Grishin SY, Aksenova AY, Deryusheva EI, Likhachev IV, Fadeev RS, Kobyakova MI, Kochetov AP, Surin AK, Gushchin VA, Galzitskaya OV. PMID: 42589407 [PubMed - indexed for MEDLINE]
	Flavonoids as Structural Probes Reveal Conformationally Dependent Ligand Recognition in the SARS-CoV-2 JN.1 Spike Protein. Int J Mol Sci Castro-Jiménez SR, Mejía A, Cabello C, Léon-Gutierrez G, Millán-Pacheco C. PMID: 42589282 [PubMed - indexed for MEDLINE]
	Novel Mechanisms of SARS-CoV-2 Drug Resistance and Rational Design of Anti-Resistant Antivirals. Molecules Bai X, Ye B, Gao S, Zhan P, Liu X. PMID: 42588503 [PubMed - indexed for MEDLINE]
	Mediterranean Diet, Redox Biomarkers, and Body Composition in ICU Post-COVID-19 Patients. Nutrients Daieni F, Carvalho BM, Medino SC, Mara SP, Aguiar MR, Magagnin WS, Catherine FS, Valesca DA. PMID: 42588043 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 291523

Page 1 of 14577



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy